Computerized Anger-Reduction Treatment for Smoking Cessation
1 other identifier
interventional
100
1 country
1
Brief Summary
Problematic anger is a strong predictor of failed attempts at smoking cessation. The investigators proposed study seeks to evaluate whether a novel 8-session computerized anger-reduction treatment improves quit rates among smokers. Smokers with elevated trait anger will be administered transdermal nicotine patch therapy and either anger-reduction treatment or a control intervention. They will be assessed throughout treatment and up until three months after a scheduled mid- treatment quit date. The investigators propose to test whether, compared to the control condition, the anger-reduction treatment will lead to: 1) greater reductions in anger and 2) greater abstinence rates at post-cessation and at follow-up assessments. The investigators will also test whether changes in anger-related symptoms account for group differences in abstinence rates.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Apr 2015
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 9, 2015
CompletedStudy Start
First participant enrolled
April 1, 2015
CompletedFirst Posted
Study publicly available on registry
April 10, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 30, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
July 30, 2019
CompletedJanuary 28, 2021
January 1, 2021
4.3 years
March 9, 2015
January 26, 2021
Conditions
Outcome Measures
Primary Outcomes (3)
State-Trait Anger Expression Inventory-2 (STAXI-2; Spielberger, 1999) state and trait subscales
up to 14-weeks following treatment initiation.
Self-reported smoking frequency
up to 14-weeks following treatment initiation.
Carbon monoxide levels
up to 14-weeks following treatment initiation.
Secondary Outcomes (6)
Minnesota Nicotine Withdrawal Scale (Hughes & Hatsukami, 1986)
up to 14-weeks following treatment initiation.
Beck Depression Inventory-II (Beck, Steer, & Brown, 1996)
Baseline and regularly for 14-weeks following treatment initiation.
Clinical Anger Scale (CAS; Snell, Gum, Shuck, Mosley, & Hite, 1995)
up to 14-weeks following treatment initiation.
WSAP-Hostility Scale (Dillon, Cougle, & Fincham, 2015)
up to 14-weeks following treatment initiation.
Hostile Automatic Thoughts Scale (Snyder, Crowson, Houston, Kurylo, & Piorier, 1997)
up to 14-weeks following treatment initiation
- +1 more secondary outcomes
Study Arms (2)
Anger Reduction Treatment
EXPERIMENTALThe treatment consists of eight 30-minute IBM sessions. Participants will be presented with ambiguous scenarios and asked imagine themselves in these situations. In the first task, the scenario will be followed by a benign interpretation of the situation. Participants will answer a comprehension question designed to have participants endorse this benign interpretation. In the second task, participants will be presented with a word denoting an interpretation with either a negative/hostile or positive/benign connotation. Following this word, an ambiguous scenario will appear. Participants will indicate whether the word and the scenario were related. They will receive feedback training them to endorse positive interpretations and reject negative interpretations.
Control Condition
PLACEBO COMPARATORParticipants assigned to the control condition will complete eight computerized sessions consisting of psychoeducation on healthy behaviors (i.e., topics of exercise, diet, hygiene, social support, healthy activities, and sleep, taken from protocols developed from our ongoing research). These participants will also view relaxing videos consisting of brief guided meditation instructions, pictures of nature scenes, and soft music. These sessions (psychoeducation and relaxing videos) will be matched for time with the active treatment condition, lasting 30 minutes each.
Interventions
Eight 30-minute sessions of interpretation modification to reduce angry interpretation biases.
Eight 30-minute sessions of informative videos on healthy living and relaxation videos.
Eligibility Criteria
You may qualify if:
- Elevated levels of trait anger (scoring 22 or higher on the STAXI-trait)
- Currently smoking an average of 8 cigarettes per day
- Must be a regular (daily) smoker for at least 1 year
- Willing to make a serious attempt to quit smoking
- Must report motivation to quit in the next month (30 days) of at least 5 on a 10 point scale (0 = no motivation and 10 = extreme motivation)
- Have not decreased the number of cigarettes by more than half in the past six months
- Must be an English speaker
You may not qualify if:
- Current substance dependence (excluding nicotine dependence)
- Current use of other tobacco products
- Currently receiving cognitive therapy or therapy for problematic anger
- Evidence of serious suicidal intent requiring hospitalization or immediate treatment
- Limited mental competency and the inability to give informed, written consent
- Evidence of psychotic-spectrum disorders
- Changes in medication over the last month
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Florida State University, Department of Psychology
Tallahassee, Florida, 32306, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jesse R Cougle, Ph.D.
Florida State University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
March 9, 2015
First Posted
April 10, 2015
Study Start
April 1, 2015
Primary Completion
July 30, 2019
Study Completion
July 30, 2019
Last Updated
January 28, 2021
Record last verified: 2021-01